Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $26000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Deferred Tax fell 99.6% year-over-year to $26000.0, compared with a TTM value of $26000.0 through Dec 2022, down 99.6%, and an annual FY2022 reading of $26000.0, down 99.6% over the prior year.
  • Long-Term Deferred Tax was $26000.0 for Q4 2022 at Cresco Labs, down from $6.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $7.1 million in Q4 2020 and bottomed at $26000.0 in Q4 2022.
  • Average Long-Term Deferred Tax over 4 years is $3.9 million, with a median of $4.2 million recorded in 2019.
  • The sharpest move saw Long-Term Deferred Tax soared 304.88% in 2020, then tumbled 99.6% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $1.8 million in 2019, then skyrocketed by 304.88% to $7.1 million in 2020, then decreased by 7.98% to $6.6 million in 2021, then crashed by 99.6% to $26000.0 in 2022.
  • Business Quant data shows Long-Term Deferred Tax for CRLBF at $26000.0 in Q4 2022, $6.6 million in Q4 2021, and $7.1 million in Q4 2020.